Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by 5gbased Telerobotic Hepatectomy

Research Leaders

16 sponsors active, led by West China Hospital

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Unknown2
Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • 5gbased Telerobotic Hepatectomy1
  • Artificial Intelligence Identifies Liver Hydatids1

Active Sponsors

  • West China Hospital2
  • Shenzhen People's Hospital1
  • Zhongshan Hospital Xiamen University1
  • Affiliated Hospital of Qinghai University1
  • Meng Chao Hepatobiliary Hospital of Fujian Medical University1

Top Investigators

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related Conditions

  • Primary Liver Cancer1
  • Jaundice1
  • Metastatic Liver Cancer1
  • Benign Liver Neoplasms1

Activity Timeline